Frontline plc Announces 2025 Annual General Meeting
Ticker: FRO · Form: 6-K · Filed: Dec 30, 2025 · CIK: 913290
Sentiment: neutral
Topics: agm, corporate-governance, filing-update
Related Tickers: FRO
TL;DR
Frontline plc (FRO) holding its 2025 AGM on Dec 8th. Standard corporate update.
AI Summary
Frontline plc announced its 2025 Annual General Meeting (AGM) via a press release filed on December 8, 2025. The company, registered in Cyprus with its principal executive offices at 8, Kennedy Street, Iris House, Off. 740B, 3106 Limassol, is a foreign private issuer filing under the 1934 Securities Exchange Act. Frontline plc is involved in the deep sea foreign transportation of freight.
Why It Matters
This filing informs shareholders about the upcoming Annual General Meeting, a key event for corporate governance and decision-making.
Risk Assessment
Risk Level: low — This is a routine corporate filing announcing an upcoming meeting, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Frontline plc (company) — Registrant
- December 8, 2025 (date) — Press Release Date
- 2025 (date) — Annual General Meeting Year
- 001-16601 (other) — Commission File Number
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report information that Frontline plc is required to disclose to its security holders, specifically attaching a press release regarding its 2025 Annual General Meeting.
When was the press release regarding the 2025 Annual General Meeting issued?
The press release regarding the 2025 Annual General Meeting was issued on December 8, 2025.
What is Frontline plc's principal executive office address?
Frontline plc's principal executive offices are located at 8, Kennedy Street, Iris House, Off. 740B, 3106 Limassol, Cyprus.
Under which SEC Act does Frontline plc file its reports?
Frontline plc files its reports under the 1934 Act, pursuant to Rule 13a-16 or 15d-16.
Does Frontline plc file annual reports under Form 20-F or Form 40-F?
Frontline plc indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 702 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2025-12-30 16:01:52
Filing Documents
- s12345678_6-k.htm (6-K) — 25KB
- image0.jpg (GRAPHIC) — 32KB
- 0000919574-25-007519.txt ( ) — 71KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. FRONTLINE PLC (registrant) Dated: December 30, 2025 By: /s/ Inger M. Klemp Name: Inger M. Klemp Title: Principal Financial Officer EXHIIT 1 FRO – 2025 Annual General Meeting 08.12.2025 Frontline plc (the "Company") advises that the 2025 Annual General Meeting of the Shareholders of the Company was held on 8 December 2025 at 09:00 a.m. at Metis Tower, 28th October Avenue and Iakovou Tombazi Street, 4th floor, 3107 Limassol, Cyprus. The audited consolidated financial statements for the Company for the year ended 31 December 2024 were presented to the Meeting. In addition, the following resolutions were passed: 1. To re-elect John Fredriksen as a Director of the Company. 2. To re-elect James O'Shaughnessy as a Director of the Company. 3. To re-elect Ola Lorentzon as a Director of the Company. 4. To re-elect Cato Stonex as a Director of the Company. 5. To re-elect rjan Svanevik as a Director of the Company. 6. To re-elect Dr. Maria Papakokkinou as a Director of the Company 7. To elect Richard C. Prince as a Director of the Company. 8. To re-appoint PricewaterhouseCoopers of Limassol, Cyprus as auditors and to authorise the Directors to determine their remuneration. 9. To approve the remuneration of the Company's Board of Directors of a total amount of fees not to exceed USD 600,000 for the year ended December 31, 2025. 10. To approve with effect from 12:00 p.m. (Cyprus time) on 08 th December, 2025 (the "Effective Date") and for a period of twelve (12) calendar months from the Effective Date the exclusion of the shareholders' right of pre-emption with respect to any offer by the Company to the public against cash consideration, as may be decided by the Board of Directors from time to time, of a maximum of 377,377,111 ordinary shares of nominal